The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference43 articles.
1. Cancer statistics, 2008;Jemal;CA Cancer J. Clin.,2008
2. Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma;Rose;J. Clin. Oncol.,1998
3. Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer;Dizon;J. Clin. Oncol.,2002
4. Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer;Gronlund;Gynecol. Oncol.,2001
5. Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel;Bookman;J. Clin. Oncol.,1998
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hypersensitivity reaction to injection hyaluronidase after multiple eye surgery: Presentation, management, and preventive strategies;Indian Journal of Ophthalmology;2024-07-29
2. Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing;Aging;2024-03-08
3. Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer;Frontiers in Oncology;2023-05-23
4. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer;Advances in Therapy;2022-04-01
5. Desensitization in patients hypersensitive to platinum compounds in gynecologic oncology;Oncology in Clinical Practice;2021-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3